- Home
- ORGO vs VHI Comparison
ORGO vs VHI Comparison
Compare ORGO & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- VHI
- Stock Information
- Founded
- ORGO 1985
- VHI 1932
- Country
- ORGO United States
- VHI United States
- Employees
- ORGO N/A
- VHI N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- VHI Major Chemicals
- Sector
- ORGO Health Care
- VHI Industrials
- Exchange
- ORGO Nasdaq
- VHI Nasdaq
- Market Cap
- ORGO 465.6M
- VHI 454.3M
- IPO Year
- ORGO N/A
- VHI N/A
- Fundamental
- Price
- ORGO $4.89
- VHI $17.67
- Analyst Decision
- ORGO Buy
- VHI Sell
- Analyst Count
- ORGO 2
- VHI 1
- Target Price
- ORGO $7.50
- VHI $12.00
- AVG Volume (30 Days)
- ORGO 642.5K
- VHI 13.2K
- Earning Date
- ORGO 08-07-2025
- VHI 08-07-2025
- Dividend Yield
- ORGO N/A
- VHI 1.84%
- EPS Growth
- ORGO N/A
- VHI 269.89
- EPS
- ORGO N/A
- VHI 3.44
- Revenue
- ORGO $429,531,000.00
- VHI $2,093,500,000.00
- Revenue This Year
- ORGO $2.57
- VHI $22.20
- Revenue Next Year
- ORGO $9.80
- VHI $7.66
- P/E Ratio
- ORGO N/A
- VHI $4.75
- Revenue Growth
- ORGO N/A
- VHI 4.04
- 52 Week Low
- ORGO $2.46
- VHI $14.10
- 52 Week High
- ORGO $6.71
- VHI $41.75
- Technical
- Relative Strength Index (RSI)
- ORGO 59.08
- VHI 59.00
- Support Level
- ORGO $4.41
- VHI $15.82
- Resistance Level
- ORGO $4.90
- VHI $17.53
- Average True Range (ATR)
- ORGO 0.30
- VHI 0.78
- MACD
- ORGO -0.03
- VHI 0.12
- Stochastic Oscillator
- ORGO 92.58
- VHI 100.00
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.